Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000, the waning days of the dot-com era. . . . → Read More: Infographic – U.S. Venture Funds Near 20-Year Highs
|
|||||
|
|
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech. . . . → Read More: Genentech, Biotech Partner on Multiple Sclerosis 
The world’s five leading technology enterprises are acquiring more companies and with more money in recent years than before. . . . → Read More: Infographic – Top Tech Acquisition Timeline 
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds 
A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds  One comment - (Comments are closed)  Finance, Joint ventures/collaborations  biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, Japan, licensing, manufacturing, pharmaceuticals, stem cells, university, venture capital 
Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions. . . . → Read More: Two Biotechs Each Issue $300M+ IPOs Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, genomics, investment, IPO, life sciences, mathematics, medical device, pharmaceuticals, physical sciences 
A start-up enterprise is developing computer chips designed to run artificial intelligence, or A.I., applications but with an architecture it says can avoid memory logjams. . . . → Read More: A.I. Chip Start-Up Raises $23M in Early Funds Comments are closed Finance, New products computer science, engineering, entrepreneurs, equity, investment, Israel, mathematics, physical sciences, semiconductors, software, venture capital 
A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable with current therapies. . . . → Read More: Company Launches Attacking Cancer Proteins, Lands $67M One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, investment, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, university, venture capital 
A new enterprise is starting up, developing early-stage cancer screening with a single blood test, based on research at Johns Hopkins University. . . . → Read More: Liquid Biopsy Screening Start-Up Launches, Gains $110M Comments are closed Finance, Intellectual property biomedical, cancer, clinical trials, entrepreneurs, equity, genomics, investment, licensing, life sciences, medical device, university, venture capital 
A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies. . . . → Read More: Viral Disease Biotech Joins ElevateBio, Gains $120M Comments are closed Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, clinical trials, entrepreneurs, equity, investment, life sciences, manufacturing, pharmaceuticals, stem cells, university, venture capital |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||